Announced Sat, 6 Jun · 15:16 IST

Intimation of Earning Conference call for the quarter Q4 of FY 2026.

Board & Shareholder Meetings View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+0.5%1-day move
₹2300.00
prior close
₹2308.85
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.4-0.6-2.9-3.1+0.5+1.1-2.2+0.0+1.4+13.7+22.2+13.0
Up moveDown movePending
AI summary

Fredun Pharmaceuticals Ltd has informed the BSE that the company will host an earnings conference call for investors and analysts to discuss its Q4 FY26 results. The call is scheduled for Wednesday, 10th June 2026 at 11:00 a.m. Mr. Fredun Medhora, Managing Director, will represent the management. The call is being organised in association with Kirin Advisors, who will facilitate the dial-in and registration process. No financial numbers or business details have been disclosed in this filing — it is purely an advance notice of the upcoming call.

Likely market impact

This is a routine procedural intimation and is unlikely to have any direct impact on the stock price. Investors should watch the call on 10th June for actual Q4 FY26 earnings details, management commentary, and any forward guidance that could move the stock.